Cargando…

Selectivity and Maximum Response of Vibegron and Mirabegron for β(3)-Adrenergic Receptors

BACKGROUND: The β(3)-adrenergic agonists vibegron and mirabegron have shown favorable safety profiles and efficacy for the treatment of overactive bladder. However, β-adrenergic receptors are also found outside the bladder, which could lead to off-target activity. OBJECTIVE: This study assessed the...

Descripción completa

Detalles Bibliográficos
Autores principales: Brucker, Benjamin M., King, Jennifer, Mudd, Paul N., McHale, Kimberly
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9184556/
https://www.ncbi.nlm.nih.gov/pubmed/35693456
http://dx.doi.org/10.1016/j.curtheres.2022.100674
_version_ 1784724547675619328
author Brucker, Benjamin M.
King, Jennifer
Mudd, Paul N.
McHale, Kimberly
author_facet Brucker, Benjamin M.
King, Jennifer
Mudd, Paul N.
McHale, Kimberly
author_sort Brucker, Benjamin M.
collection PubMed
description BACKGROUND: The β(3)-adrenergic agonists vibegron and mirabegron have shown favorable safety profiles and efficacy for the treatment of overactive bladder. However, β-adrenergic receptors are also found outside the bladder, which could lead to off-target activity. OBJECTIVE: This study assessed the selectivity of vibegron and mirabegron for β-adrenergic receptors and the maximal effect and potency for β(3)-adrenergic receptors. METHODS: Functional cellular assays were performed using Chinese hamster ovary-K1 cells expressing β(1)-, Chinese hamster ovary cells expressing β(2)-, and human embryonic kidney 293 cells expressing β(3)-adrenergic receptors. Cells were incubated with vibegron, mirabegron, or control (β(1) and β(3), isoproterenol; β(2), procaterol). Responses were quantified using homogeneous time-resolved fluorescence of cyclic adenosine monophosphate and were normalized to the respective control. Half-maximal effective concentration and maximum response values were determined by nonlinear least-squares regression analysis. RESULTS: Activation of β(3)-adrenergic receptors with vibegron or mirabegron resulted in concentration-dependent β(3)-adrenergic receptor responses. Mean (SEM) half-maximal effective concentration values at β(3)-adrenergic receptors were 2.13 (0.25) nM for vibegron and 10.0 (0.56) nM for mirabegron. At a concentration of 10 µM, β(3)-adrenergic activity relative to isoproterenol was 104% for vibegron and 88% for mirabegron. Maximum response at β(3)-adrenergic receptors was 99.2% for vibegron and 80.4% for mirabegron. β(1)-adrenergic activity was 0% and 3% for vibegron and mirabegron, respectively; β(2)-adrenergic activity was 2% and 15%, respectively. CONCLUSIONS: Vibegron showed no measurable β(1) and low β(2) activity compared with mirabegron, which showed low β(1) and some β(2) activity. Both showed considerable selectivity at β(3)-adrenergic receptors; however, vibegron demonstrated near-exclusive β(3) activity and a higher maximum β(3) response.
format Online
Article
Text
id pubmed-9184556
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-91845562022-06-11 Selectivity and Maximum Response of Vibegron and Mirabegron for β(3)-Adrenergic Receptors Brucker, Benjamin M. King, Jennifer Mudd, Paul N. McHale, Kimberly Curr Ther Res Clin Exp Brief Report BACKGROUND: The β(3)-adrenergic agonists vibegron and mirabegron have shown favorable safety profiles and efficacy for the treatment of overactive bladder. However, β-adrenergic receptors are also found outside the bladder, which could lead to off-target activity. OBJECTIVE: This study assessed the selectivity of vibegron and mirabegron for β-adrenergic receptors and the maximal effect and potency for β(3)-adrenergic receptors. METHODS: Functional cellular assays were performed using Chinese hamster ovary-K1 cells expressing β(1)-, Chinese hamster ovary cells expressing β(2)-, and human embryonic kidney 293 cells expressing β(3)-adrenergic receptors. Cells were incubated with vibegron, mirabegron, or control (β(1) and β(3), isoproterenol; β(2), procaterol). Responses were quantified using homogeneous time-resolved fluorescence of cyclic adenosine monophosphate and were normalized to the respective control. Half-maximal effective concentration and maximum response values were determined by nonlinear least-squares regression analysis. RESULTS: Activation of β(3)-adrenergic receptors with vibegron or mirabegron resulted in concentration-dependent β(3)-adrenergic receptor responses. Mean (SEM) half-maximal effective concentration values at β(3)-adrenergic receptors were 2.13 (0.25) nM for vibegron and 10.0 (0.56) nM for mirabegron. At a concentration of 10 µM, β(3)-adrenergic activity relative to isoproterenol was 104% for vibegron and 88% for mirabegron. Maximum response at β(3)-adrenergic receptors was 99.2% for vibegron and 80.4% for mirabegron. β(1)-adrenergic activity was 0% and 3% for vibegron and mirabegron, respectively; β(2)-adrenergic activity was 2% and 15%, respectively. CONCLUSIONS: Vibegron showed no measurable β(1) and low β(2) activity compared with mirabegron, which showed low β(1) and some β(2) activity. Both showed considerable selectivity at β(3)-adrenergic receptors; however, vibegron demonstrated near-exclusive β(3) activity and a higher maximum β(3) response. Elsevier 2022-05-14 /pmc/articles/PMC9184556/ /pubmed/35693456 http://dx.doi.org/10.1016/j.curtheres.2022.100674 Text en © 2022 The Authors https://creativecommons.org/licenses/by/4.0/This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Brief Report
Brucker, Benjamin M.
King, Jennifer
Mudd, Paul N.
McHale, Kimberly
Selectivity and Maximum Response of Vibegron and Mirabegron for β(3)-Adrenergic Receptors
title Selectivity and Maximum Response of Vibegron and Mirabegron for β(3)-Adrenergic Receptors
title_full Selectivity and Maximum Response of Vibegron and Mirabegron for β(3)-Adrenergic Receptors
title_fullStr Selectivity and Maximum Response of Vibegron and Mirabegron for β(3)-Adrenergic Receptors
title_full_unstemmed Selectivity and Maximum Response of Vibegron and Mirabegron for β(3)-Adrenergic Receptors
title_short Selectivity and Maximum Response of Vibegron and Mirabegron for β(3)-Adrenergic Receptors
title_sort selectivity and maximum response of vibegron and mirabegron for β(3)-adrenergic receptors
topic Brief Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9184556/
https://www.ncbi.nlm.nih.gov/pubmed/35693456
http://dx.doi.org/10.1016/j.curtheres.2022.100674
work_keys_str_mv AT bruckerbenjaminm selectivityandmaximumresponseofvibegronandmirabegronforb3adrenergicreceptors
AT kingjennifer selectivityandmaximumresponseofvibegronandmirabegronforb3adrenergicreceptors
AT muddpauln selectivityandmaximumresponseofvibegronandmirabegronforb3adrenergicreceptors
AT mchalekimberly selectivityandmaximumresponseofvibegronandmirabegronforb3adrenergicreceptors